Over one million children in this country per year are delivered to women who have used alcohol, tobacco, marijuana, or illicit drugs during pregnancy. This webinar series will explore the biological and environmental factors for mothers, children and families that impact the ultimate development of children affected by prenatal substance exposure and provide an overview of family- and school-based intervention strategies that can promote long-term growth and development of this high-risk population of children.
Neonatal abstinence syndrome [NAS] is a diagnosis that originally was restricted to infants going through withdrawal due to the effects of prenatal opioid exposure. However, over time, the term began to be applied to infants with jitteriness and irritability following prenatal exposure to other substances. A new term, Neonatal Opioid Withdrawal Syndrome (NOWS), recently emerged to ensure specificity in the diagnosis of infants affected by prenatal exposure to opioids. Whichever term is used, how do clinicians differentiate the effects of and infants’ dependence on opioids from infants with neurobehavioral deficits due to non-opioid exposure. This session will address that question and provide an effective approach to diagnosing NOWS in the newborn infant.
At the completion of this session, participants will be able to:
Describe the neurobehavioral deficits exhibited in infants with prenatal exposure to non-opioid substances.
Differentiate NOWS from neurobehavioral deficits in infants affected by prenatal non-opioid substance exposure.
CHA Education Services
Ira J. Chasnoff, MD, an award-winning author, researcher and lecturer, is president of NTI Upstream and a Professor of Clinical Pediatrics at the University of Illinois College of Medicine in Chicago. He is one of the nation’s leading researchers in the field of child development and the effects of environmental factors on the developmental trajectory of children and adolescents. Dr. Chasnoff’s work encompasses community approaches to the integration of behavioral health services into primary healthcare, the schools, and the other multiple systems that serve children and families. Dr. Chasnoff has served several U.S. presidential administrations on committees and commissions dedicated to organizing and coordinating services for children and families across the nation, and developing policies and procedures for addressing the needs of children at risk from prenatal and postnatal trauma. He also has worked with a wide range of States across the nation and internationally in developing universal outreach and early intervention programs for children and families affected by trauma or substance abuse. Dr. Chasnoff received his medical degree from the University of Texas Health Science Center at San Antonio, which in 1991 awarded him its first Distinguished Alumnus Award. He is the author of numerous research articles regarding the long-term cognitive, behavioral, and learning outcomes of high-risk children, and his article on racial and social class bias in the healthcare system has been cited as a landmark study by the American College of Obstetricians and Gynecologists. Dr. Chasnoff has authored 15 books, which have received numerous awards and one of which has been recognized by The Hague International Court. Dr. Chasnoff’s books explore the biological and environmental factors that impact the ultimate development of high-risk children and presents practical strategies for helping children reach their full potential at home and in the classroom. His newest book, Guided Growth, has received international acclaim for its in-depth discussion of educational and behavioral interventions for children and teens with Fetal Alcohol Spectrum Disorders and early trauma.
This course is provided by Connecticut Hospital Association.